← Evidence map

ArticleJournal of the National Cancer Institute2016

RE: BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Eloisa Arbustini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2016

2017

2018

2019

2020

2021

this papercites it

RE: BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. | OpenQuestion